Sanofi - 23 Apr 2025 SCHEDULE 13G/A Report for Innate Pharma SA Ordinary Shares, Euro 0.05 nominal value per share

Filing Manager: Sanofi
Reporting Manager: SANOFI
Security: Innate Pharma SA Ordinary Shares, Euro 0.05 nominal value per share
Shares outstanding: 92.2M shares
Disclosed Ownership: 8.35M shares
Ownership: 9.05%
Form type: SCHEDULE 13G/A
Filing time: 29 Apr 2025, 18:48:10 UTC
Date of event: 23 Apr 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
SANOFI	9.05%	8.35M	8.35M	0	/s/ Alexandra Roger	Alexandra Roger, Head of Legal Corporate and Finance